OA09023A - Composition pharmaceutique, administrable par voie orale, destinée à réduire les effets des b-lactamines. - Google Patents

Composition pharmaceutique, administrable par voie orale, destinée à réduire les effets des b-lactamines.

Info

Publication number
OA09023A
OA09023A OA59487A OA59487A OA09023A OA 09023 A OA09023 A OA 09023A OA 59487 A OA59487 A OA 59487A OA 59487 A OA59487 A OA 59487A OA 09023 A OA09023 A OA 09023A
Authority
OA
OAPI
Prior art keywords
lactams
effects
intended
reduce
pharmaceutical composition
Prior art date
Application number
OA59487A
Other languages
English (en)
French (fr)
Inventor
Tancrede Cyrille
Andremont Antoine
Labia Roger
Leonard Florence
Original Assignee
Roussy Inst Gustave
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussy Inst Gustave filed Critical Roussy Inst Gustave
Publication of OA09023A publication Critical patent/OA09023A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
OA59487A 1987-04-10 1988-12-09 Composition pharmaceutique, administrable par voie orale, destinée à réduire les effets des b-lactamines. OA09023A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8705110A FR2613624B1 (fr) 1987-04-10 1987-04-10 Composition pharmaceutique, administrable par voie orale, destinee a reduire les effets des b-lactamines

Publications (1)

Publication Number Publication Date
OA09023A true OA09023A (fr) 1991-03-31

Family

ID=9350003

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59487A OA09023A (fr) 1987-04-10 1988-12-09 Composition pharmaceutique, administrable par voie orale, destinée à réduire les effets des b-lactamines.

Country Status (8)

Country Link
EP (1) EP0309532A1 (xx)
JP (1) JPH01503537A (xx)
AU (1) AU604117B2 (xx)
FR (1) FR2613624B1 (xx)
OA (1) OA09023A (xx)
PT (1) PT87190B (xx)
WO (1) WO1988007865A1 (xx)
ZA (1) ZA882426B (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI920206A0 (fi) * 1992-01-17 1992-01-17 Pekka Untamo Heino Medicinsk anvaendning, medicinskt foerfarande och preparat.
FR2843302B1 (fr) 2002-08-09 2004-10-22 Centre Nat Rech Scient Forme galenique pour la delivrance colique de principes actifs
US8273376B2 (en) 2006-11-17 2012-09-25 Da Volterra Colonic delivery of metallo-dependent enzymes
FI20105572A0 (fi) 2010-05-24 2010-05-24 Prevab R Lcc Muokattu beeta-laktamaasi ja siihen liittyvät menetelmät ja käytöt
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
WO2015161243A2 (en) 2014-04-17 2015-10-22 Synthetic Biologics, Inc. Beta-lactamases with improved properties for therapy
CN106574273B (zh) 2014-08-28 2021-07-02 合成生物制品有限公司 β-内酰胺酶的基于大肠杆菌的生产
CN107148473B (zh) 2014-10-08 2021-08-06 合成生物制品有限公司 β-内酰胺酶制剂及其用途
JP6427278B2 (ja) 2014-12-23 2018-11-21 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ ｐｉｒｉｎポリペプチド及び免疫モジュレーション
EP3236993B1 (en) 2014-12-23 2023-09-13 Theriva Biologics, Inc. Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics
SI3065748T1 (en) 2014-12-23 2018-05-31 4D Pharma Research Limited Severe bacteroid tethethioomycron and its use in reducing inflammation
JP6810697B2 (ja) 2015-02-23 2021-01-13 シンセティック・バイオロジクス・インコーポレイテッド 腸内マイクロバイオームの保護のために抗生物質と共に使用するカルバペネマーゼ
AU2016229976B2 (en) 2015-03-06 2021-11-11 Theriva Biologics, Inc. Safe and effective beta-lactamase dosing for microbiome protection
CN114984057A (zh) 2015-06-15 2022-09-02 4D制药研究有限公司 包含细菌菌株的组合物
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
RS59446B1 (sr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Blautia stercosis i wexlerae za upotrebu u lečenju inflamatornih i autoimunskih bolesti
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
SI3360559T1 (sl) 2015-06-15 2020-02-28 4D Pharma Research Limited Sestavki, ki vsebujejo bakterijske seve
EP3209310B1 (en) 2015-11-20 2018-01-31 4D Pharma Research Limited Compositions comprising bacterial strains
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
NZ745678A (en) 2016-03-04 2019-03-29 4D Pharma Plc Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
AU2018272291A1 (en) 2017-05-22 2020-01-16 4D Pharma Research Limited Compositions comprising bacterial strains
TW201907931A (zh) 2017-05-24 2019-03-01 英商4D製藥研究有限公司 包含細菌菌株之組合物
CN111107859B (zh) 2017-06-14 2022-04-29 4D制药研究有限公司 包含细菌菌株的组合物
HUE052319T2 (hu) 2017-06-14 2021-04-28 4D Pharma Res Ltd Baktériumtörzseket tartalmazó készítmények
ES2917415T3 (es) 2017-06-14 2022-07-08 4D Pharma Res Ltd Composiciones que comprenden una cepa bacteriana

Also Published As

Publication number Publication date
AU1578688A (en) 1988-11-04
PT87190A (pt) 1988-05-01
PT87190B (pt) 1992-08-31
ZA882426B (en) 1988-09-28
AU604117B2 (en) 1990-12-06
FR2613624A1 (fr) 1988-10-14
WO1988007865A1 (fr) 1988-10-20
EP0309532A1 (fr) 1989-04-05
JPH01503537A (ja) 1989-11-30
FR2613624B1 (fr) 1990-11-23

Similar Documents

Publication Publication Date Title
OA09023A (fr) Composition pharmaceutique, administrable par voie orale, destinée à réduire les effets des b-lactamines.
DZ1077A1 (fr) Nouvelles préparation pharmaceutique pour administration orale.
BE896205A (fr) Nouvelles formulations pharmaceutiques contenant le coenzyme q10 adaptees pour l'administration topique
IE862554L (en) Pharmaceutical compositions
PT87820A (pt) Process for the preparation of 1,2,3,5,6-tetrahydro-pyridile anof pyperidile compounds and pharmaceutical compositions therewi
MX9203263A (es) Composicion farmaceutica analgesica para administracion nasal.
BE849632A (fr) Composition pharmaceutique pour l'administration orale
IT1210666B (it) Preparato farmaceutico ad assorbimento percutaneo per il trattamento di angina pectoris
IT8619625A0 (it) Composizioni farmaceutiche per inalazione.
IT8621358A0 (it) Composizione farmaceutica adattivita' analgesica.
ITMI912212A0 (it) Composizioni farmaceutiche solide per somministrazione orale aventi proungata residenza gastrica
IT1190824B (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
IT8119673A0 (it) Composizioni farmaceutiche per il trattamento di osteopatie.
MA22443A1 (fr) Procede de preparation d'une composition pharmaceutique .
FI883673A (fi) Farmaceutiska kompositioner.
ATE90339T1 (de) Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel.
IT8722031A0 (it) Formulazioni farmaceutiche e forme di dosaggio per la somministrazione rettale di calcitonina.
IT1210935B (it) Composizione farmaceutica per il trattamento di malattie cardiovascolari.
ZA826453B (en) Tricyclic thiazolyloxamic acids and their derivatives,their preparation,and therapeutic agents containing these compounds
NO873514D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive forbindelser.
OA06135A (fr) Composition pharmaceutique administrable par voie orale.
OA08609A (fr) Composition pharmaceutique pour le traitement des infections bactériennes.
FR2673105B1 (fr) Nouvelles compositions pharmaceutiques, notamment pour le traitement des colopathies fonctionnelles, et procedes de preparation de compositions et de medicaments, notamment pour le traitement de ces affections.
IT8221120A0 (it) Composizione farmaceutica per combattere l'aggregazione delle piastrine.
IT8720034A0 (it) Composizioni farmaceutiche per il trattamento di sindromi psico-organiche cerebrali.